• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

FDA grants IND clearance for Indapta’s multiple sclerosis treatment trial

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 07, 2024 at 11:42: AM
via Indapta Therapeutics has received clearance from the US Food and Drug Administration (FDA) for its investigational new drug (IND) application, enabling a future Phase I clinical trial of IDP-023 to treat progressive multiple sclerosis (MS).

article source
 






Top Bottom
Back
Quote